EL.En. S.p.A.
EL.En. S.p.A. (ELEAF) Financial Performance & Income Statement Overview
Analyze EL.En. S.p.A. (ELEAF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
EL.En. S.p.A. (ELEAF) Income Statement & Financial Overview
Explore comprehensive income reports for EL.En. S.p.A. ELEAF, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $99.62M | $153.26M | $159.86M | $153.10M |
| Cost of Revenue | $43.80M | $93.23M | $99.31M | $90.70M |
| Gross Profit | $55.82M | $60.04M | $60.55M | $62.40M |
| Gross Profit Ratio | $0.56 | $0.39 | $0.38 | $0.41 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $5.24M |
| SG&A Expenses | $0.00 | $0.00 | $42.97M | $43.18M |
| Operating Expenses | $28.39M | $43.34M | $60.55M | $48.08M |
| Total Costs & Expenses | $72.19M | $136.56M | $282.89M | $138.78M |
| Interest Income | $0.00 | $0.00 | $0.00 | $187000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $3.96M | $3.90M | $5.97M | $4.90M |
| EBITDA | $34.50M | $20.60M | $46.64M | $12.90M |
| EBITDA Ratio | $0.35 | $0.13 | $0.29 | $0.08 |
| Operating Income | $27.43M | $16.70M | $30.07M | $10.73M |
| Operating Income Ratio | $0.28 | $0.11 | $0.19 | $0.07 |
| Other Income/Expenses (Net) | $2.87M | -$1.39M | -$5.97M | $80000.00 |
| Income Before Tax | $30.29M | $15.31M | $24.10M | $14.40M |
| Income Before Tax Ratio | $0.30 | $0.10 | $0.15 | $0.09 |
| Income Tax Expense | $21.23M | $0.00 | $11.05M | $3.58M |
| Net Income | -$2.20M | $15.31M | $12.90M | $14.40M |
| Net Income Ratio | -$0.02 | $0.10 | $0.08 | $0.09 |
| EPS | -$0.03 | $0.19 | $0.16 | $0.18 |
| Diluted EPS | -$0.03 | $0.19 | $0.16 | $0.18 |
| Weighted Avg Shares Outstanding | $80.09M | $80.07M | $79.97M | $79.97M |
| Weighted Avg Shares Outstanding (Diluted) | $80.11M | $80.07M | $82.72M | $79.97M |
The company's financials show resilient growth, with revenue advancing from $153.10M in Q1 2024 to $99.62M in Q4 2024. Gross profit remained healthy with margins at 56% in Q4 2024 compared to 41% in Q1 2024. Operating income hit $27.43M last quarter, sustaining a consistent 28% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $34.50M. Net income dropped to -$2.20M, while earnings per share reached -$0.03. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan